Process for performing an isolated Pd(II)-mediated oxidation reaction
申请人:Moeller D. Kevin
公开号:US20060205959A1
公开(公告)日:2006-09-14
There is disclosed a process for performing an isolated Pd(II) mediated oxidation reaction electrochemically. The inventive process is performed on an electrode array device having a plurality of separately addressable electrodes. Preferably, the Pd(II) mediated oxidation is a Wacker reaction. Specifically, there is disclosed a process for conducting an isolated Pd(II) mediated oxidation on a plurality of electrodes, comprising providing an electrode array device having a plurality of electrodes with a conductive electrode surface and a matrix or coating material over the electrodes surfaces; providing a solution bathing the electrode array matrix or coating material and electrode surfaces, wherein the solution comprises a transition metal species and a confining agent; and biasing one or a plurality of electrodes (“selected electrode or electrodes”) with a voltage or current to regenerate the transition metal species required for the isolated Pd(II) mediated oxidation, whereby the confining agent limits diffusion of the transition metal species to a volume surrounding each selected electrode surface.
[EN] SALTS OF A ISOCHROMANYL COMPOUND AND CRYSTALLINE FORMS, PROCESSES FOR PREPARING, THERAPEUTIC USES, AND PHARMACEUTICAL COMPOSITIONS THEREOF<br/>[FR] SELS D'UN COMPOSÉ D'ISOCHROMANYLE ET FORMES CRISTALLINES, PROCÉDÉS DE PRÉPARATION, UTILISATIONS THÉRAPEUTIQUES ET COMPOSITIONS PHARMACEUTIQUES ASSOCIÉES
申请人:SUNOVION PHARMACEUTICALS INC
公开号:WO2020186165A1
公开(公告)日:2020-09-17
The present disclosure relates to salts of (R)-1-(8-fluoroisochroman-1-yl)-N-methylmethanamine, crystalline forms thereof, and methods of preparation thereof, which are useful in the treatment of CNS disorders.
Novel pyridine or 1,2,3,4-tetrahydropyridine derivatives useful as psychotropic drugs and represented by general formula (I) or (II),
wherein A represents S or 0 and, with respect to general formula (I), R1 does not represent any alkoxy group.
通式(I)或(II)表示的可用作精神药物的新型吡啶或 1,2,3,4-四氢吡啶衍生物、
其中 A 代表 S 或 0,就通式(I)而言,R1 不代表任何烷氧基。
In mold coating compositions
申请人:GENCORP INC.
公开号:EP0461320A1
公开(公告)日:1991-12-18
An FRP molding can be in-mold coated using a free radical peroxide initiated thermosetting composition of at least one polymerizable epoxy based oligomer having at least two acrylate groups, at least one copolymerizable ethylenically unsaturated monomer, at least one copolymerizable monoethylenically unsaturated compound having a -CO- group and a -NH₂, -NH- and/or -OH group, polyvinyl acetate, at least one zinc salt of a fatty acid, at least one calcium salt of a fatty acid, at least one accelerator for a peroxide initiator, conductive carbon black, a filler such as talc and containing as an additive a soluble ionic organic salt, which is an ammonium arylsulphonate, e.g. tetraethylammonium p-toluenesulphonate.
Composition for film formation, method of film formation, and silica-based film
申请人:JSR CORPORATION
公开号:US20030091838A1
公开(公告)日:2003-05-15
A composition for film formation which comprises:
(A) a product of hydrolysis and condensation obtained by hydrolyzing and condensing at least one silane compound selected from the group consisting of compounds represented by the formula (1), compounds represented by the formula (2), and compounds represented by the formula (3) in the presence of water and an ammonium compound, and
(B) an organic solvent.